Ciprofloxacin Capsule Manufacturer in India

About

About Ciprofloxacin Capsules — 9M India

9M India manufactures Ciprofloxacin hard gelatin capsules at its WHO-GMP certified facility in Birkoni, Chhattisgarh. Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic with activity against a wide range of gram-positive and gram-negative bacteria. Available in 250mg and 500mg strengths, our Ciprofloxacin capsules conform to BP/USP pharmacopoeial standards and are supported by complete in-house analytical testing, stability studies and export documentation.

Capsule formulation specifications

Specification	Details
Molecule	Ciprofloxacin Hydrochloride
Dosage Form	Hard Gelatin Capsule
Available Strengths	250mg, 500mg
Pharmacopoeial Standard	BP / USP / IP
Therapeutic Class	Antibiotic — Fluoroquinolone
Pack Options	10 capsules per strip; bulk packs available
Storage	Store below 30°C, protect from light and moisture
Shelf Life	24 months
MOQ	As per enquiry — contact us

Therapeutic use & clinical indications

Ciprofloxacin belongs to the fluoroquinolone class and acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication. It demonstrates broad-spectrum bactericidal activity and is a first-line agent for a range of urinary, respiratory and gastrointestinal infections.

Primary Indications:

Urinary tract infections — complicated and uncomplicated
Lower respiratory tract infections
Acute sinusitis
Bone and joint infections
Typhoid fever and enteric infections
Infectious diarrhoea

Enquire Now

Export markets & regulatory

Export markets & regulatory readiness

9M India exports Ciprofloxacin capsules to regulated and semi-regulated markets across the Middle East, Africa, CIS countries, ASEAN and Latin America. All formulations are manufactured under WHO-GMP conditions and supported by complete regulatory documentation including CTD/ACTD dossiers, Certificate of Pharmaceutical Product (CoPP), Free Sale Certificate (FSC), and Certificate of Analysis (CoA).

WHO-GMP Certificate
DCGI Manufacturing Licence
Certificate of Pharmaceutical Product (CoPP)
Certificate of Analysis (CoA) — batch-wise
CTD / ACTD Dossier — on request
Stability Data — ICH Zone IVb (30°C/75% RH)

Partner with 9M India for Ciprofloxacin capsule supply

Whether you are a pharmaceutical distributor, institutional buyer, government procurement agency or export partner, 9M India is equipped to supply Ciprofloxacin capsules at scale — with full regulatory support and flexible packaging options.

Submit An Enquiry

View All Capsule Categories

WHO-GMP
Certified
Export
Ready
15+ Countries
Supplied
DCGI
Approved

Submit An Enquiry

View All Capsule Categories

We keep answer short

Frequently asked questions — Ciprofloxacin capsules

01

Yes. 9M India Limited manufactures Ciprofloxacin hard gelatin capsules at its WHO-GMP certified facility in Birkoni, Chhattisgarh. All formulations are DCGI approved and export-ready with full regulatory documentation.
02

9M India manufactures Ciprofloxacin Hydrochloride hard gelatin capsules in 250mg and 500mg strengths. Both are available for institutional supply and international export.
03

Our Ciprofloxacin capsules conform to BP (British Pharmacopoeia), USP (United States Pharmacopoeia) and IP (Indian Pharmacopoeia) standards. Analytical testing is performed in-house with results documented in the Certificate of Analysis provided with each batch.
04

Yes. 9M India regularly supplies to institutional buyers and government procurement programmes. We support large-volume orders with flexible packaging options and complete documentation for tender compliance.
05

Ciprofloxacin capsules manufactured by 9M India have a shelf life of 24 months from the date of manufacture when stored below 30°C, protected from light and moisture. Stability data is available as per ICH Zone IVb guidelines.
06

Yes. 9M India provides CTD and ACTD format dossiers for Ciprofloxacin capsules on request. Our regulatory documentation team can assist export partners with dossier preparation requirements for their target markets.